Skip to main content
. Author manuscript; available in PMC: 2013 Feb 1.
Published in final edited form as: J Cardiovasc Pharmacol. 2012 Feb;59(2):116–123. doi: 10.1097/FJC.0b013e3182244a12

Figure 3.

Figure 3

Schematic representation of the proposed bi-modal effect of prostaglandin E2. In the presence of certain modulators, such as IL-12 or IL-23, a low concentration of prostaglandin E2 results in pro-inflammatory signals. Conversely, a high concentration of prostaglandin E2 leads to anti-inflammatory responses. Modulators such as L-ornithine decrease proliferation of CD8+ T cells, thereby preventing anti-inflammatory action.